A PET study of [11C]β-CIT-FE binding to the dopamine transporter in the monkey and human brain

International Journal of Neuropsychopharmacology

Volumn 3, Issue 3, 2000, Pages 203-214

  Farde, Lars ^a   Ginovart, Nathalie ^a   Halldin, Christer ^a   Chou, Yuan Hwa ^a   Olsson, Hans ^a   Swahn, Carl Gunnar ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Brain; Dopamine transporter; Human; Monkey; PET

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE TRANSPORTER; MAPROTILINE; N (2 FLUOROETHYL) 2BETA CARBOMETHOXY 3BETA (4 IODOPHENYL)NORTROPANE; RACLOPRIDE; RADIOLIGAND; UNCLASSIFIED DRUG; VANOXERINE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG SPECIFICITY; DRUG UPTAKE; HUMAN; HUMAN EXPERIMENT; MALE; MONKEY; NONHUMAN; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; RADIOISOTOPE DISTRIBUTION; THALAMUS; TISSUE DISTRIBUTION;

EID: 0033807875     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145700002030     Document Type: Article

References (55)

1. SPECT Imaging of dopamine transporters in human brain with Iodine-123-Fluoroalkyl analogs of β-CIT
2. A new look at the statistical model identification
3. The dopamine uptake inhibitor GBR 12909: Selectivity and molecular mechanisms of action
4. 123I]N-o-Fluoroalkyl-2β-carboxy-3β-(4-iodophenyl)-nortropane esters in baboons
5. Characterization of C-11 and I-123 labelled β-CIT-FP and β-CIT-FE metabolism measured in monkey and human plasma. Identification of two labelled metabolites with HPLC
6. Head fixation device for reproducible position alignment in transmission CT and positron emission tomography
7. 3H]mazindol autoradiography
8. Automated blood sampling systems for positron emission tomography
9. 2-dopamine receptors studied by PET - A comparison to the equilibrium analysis
10. 2 dopamine receptor binding in the living human brain by PET
11. 11C]raclopride in man
12. 11C]β-CIT binding to monoamine transporters in the monkey and human brain
13. 11C]WAY-100635 binding to central 5-HT1A-receptors in man
14. 2-dopamine receptors by PET
15. 11C]WIN 35.428 reveals marked declines in mild Parkinson's disease
16. PET-study of pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease
17. 125I]β-CIT for dopamine transporter visualization: Autoradiographic evaluation in the human brain
18. 11C]β-CIT-FE, a radioligand for quantitation of the dopamine transporter in the living brain using positron emission tomography
19. Effects of temporal sampling, glucose metabolic rates, and disruptions of the blood-brain barrier on the FDG model with and without a vascular compartment. Studies in human brain tumors with PET
20. Neuroreceptor assay with positron emission tomography. Equilibrium versus dynamic approaches
21. Citalopram: Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity
22. 123I]CIT
23. Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinsons' disease
24. 11C]raclopride binding
25. PET imaging of central 5-HT(2a) receptors with carbon-11-MDL 100,907
26. 3H]mazindol autoradiography
27. 1-dopamine receptors
28. 11C]aminocyclo- hexanecarboxylate for the measurement of amino acid uptake and distribution volume in human brain
29. Iodine-123 labelled N-(2-fluoroethyl)-2β-carbomethoxy-3β-(4-iodophenyl)nortropane for dopamine transporter imaging in the living human brain
30. 18F]WIN 35,428), a radioligand to study the dopamine transporter with PET: Characterization in human subjects
31. PET studies on brain monoamine transporters with carbon-11-beta-CIT in Parkinson's disease
32. Kinetic modeling of receptor-ligand binding applied to positron emission tomographic studies with neuroleptic tracers
33. 11C]methyl triflate
34. 3H]2beta-carbomethoxy-3beta-(4-fluorophenyl)tropane
35. 123I]β-CIT SPECT measures of dopamine transporter availability in human cocaine addicts
36. An algorithm for least-squares estimation of nonlinear parameters
37. 3H-GBR 12935
38. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography
39. 11C-CFT
40. 11C]β-CIT, a cocaine analogue. Preparation, autoradiography and preliminary PET investigations
41. N-substituted analogs of 2-beta- carboxymethoxy-3 beta-(4'-iodophenyl)tropane (beta-CIT) with selective affinity to dopamine or serotonin transporters in rat forebrain
42. N-o-Fluoroalkyl analogs of (1R)-2β-carbomethoxy-3β-[4-iodophenyl)tropane (β-CIT): Radiotracers for PET and SPECT imaging of dopamine transporters
43. 123I]-2β-carbomethoxy-3β-(4-iodophenyl)-tropane: High-affinity SPECT radiotracer of monoamine reuptake sites in brain
44. Assessment of affinities of β-CIT, β-CIT-FE, and β-CIT-FP for monoamine transporters permanently expressed in cell lines
45. 11C]methylspiperone binding in vivo: Positron emission tomography study using conscious rhesus monkey
46. Maprotiline: A review of its pharmacological properties and therapeutic efficacy in mental depressive states
47. 125I]RTI-55 in membranes prepared from human, monkey and guinea pig caudate
48. [(123/125I)]RTI-55, an in vivo label for the serotonin transporter
49. Estimating the dimension of a model
50. In vivo imaging of dopamine reuptake sites in the primate brain using single photon emission computed tomography (SPECT) and Iodine-123 labeled RTI-55
51. Altered striatal dopamine reuptake site densities in habitually violent and non-violent alcoholics
52. A ketamine mixture anesthetic inhibits neuroendocrine and behavioral consequences of cocaine administration
53. Relationship between subjective effects of cocaine and dopamine transporter occupancy
54. The ECAT EXACT HR: Performance of a new high resolution positron scanner
55. Reduction in regional cerebral metabolic rate of oxygen during human aging